ARTICLE | Company News
Aptus, Array GPCR deal
April 5, 2002 8:00 AM UTC
Aptus Genomics (Gaithersburg, Md.) and ARRY will develop small molecule compounds against G protein-coupled receptor (GPCR) targets. Aptus will use its AptuScreen GPCR technology to screen ARRY Lead G...